FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to new compounds of formulas
and 
or pharmaceutically acceptable salts thereof, wherein the values R1-R13, Ra, Rb, Rc, Rd, Rf, Rq, n are presented in the patent claim possessing the properties of protein p53 activator.
EFFECT: compounds may be used in treating cancer and diseases caused by a fungal, bacterial or parasitic infection, eg malaria.
16 cl, 38 dwg, 12 tbl, 16 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INDUCING CELL DEATH BY INHIBITION OF ADAPTIVE HEAT SHOCK RESPONSE | 2009 |
|
RU2474612C2 |
| FLUORINE-18 AND CARBON-11 LABELED RADIOLIGANDS FOR POSITRON EMISSION TOMOGRAPHY (PET) IMAGING FOR LRRK2 | 2012 |
|
RU2650641C2 |
| 3-AMINO-1-ARYLPROPYLINDOLES APPLIED AS INHIBITOR MONOAMINE REUPTAKE | 2005 |
|
RU2382031C2 |
| DIAZEPANE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTORS | 2007 |
|
RU2439065C2 |
| NOVEL PYRIMIDINE DERIVATIVES AND THEIR APPLICATION IN THERAPY, AS WELL AS APPLICATION OF PYRIMIDINE DERIVATIVES IN MANUFACTURING MEDICATION FOR PREVENTION AND/OR TREATMENT OF ALZHEIMER'S DISEASE | 2006 |
|
RU2433128C2 |
| MACROCYCLIC SERINE PROTEASE INHIBITORS | 2009 |
|
RU2490272C2 |
| PYRAZOLAMINOPIRIMIDINE DERIVATIVES AS LEUCINE-REPEATING KINASE 2 (LRRK2) MODULATORS FOR TREATMENT OF PARKINSON DISEASE | 2013 |
|
RU2637948C2 |
| PYRROLOTRIAZINE ANILINE DERIVATIVES EFFECTIVE AS KINASE INHIBITORS | 2003 |
|
RU2375363C2 |
| INTERMEDIATE PRODUCTS IN SYNTHESIS OF ANALOGUES OF ZEARALENONE MACROLIDES | 2008 |
|
RU2497803C2 |
| HETEROCYCLIC COMPOUNDS AND USES THEREOF | 2014 |
|
RU2680100C9 |
